Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
Open Access
- 24 June 2019
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 23 (1) , 1-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated CoagulopathyJAMA, 2019
- Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisJAMA, 2019
- Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysisCritical Care, 2018
- Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitroJournal of Intensive Care, 2016
- NETosis: how vital is it?Blood, 2013